» Authors » J Kirchgesner

J Kirchgesner

Explore the profile of J Kirchgesner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 178
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salin G, Corpechot C, Ouazana S, Dong C, Becq A, Lemoinne S, et al.
Clin Res Hepatol Gastroenterol . 2024 Mar; 48(5):102324. PMID: 38527568
Background And Objective: LPAC (low phospholipid-associated cholelithiasis) syndrome is a rare genetic form of cholelithiasis. ERCP (endoscopic retrograde cholangiopancreatography) is often used to remove gallstones in the bile duct. No...
2.
Kucharzik T, Ellul P, Greuter T, Rahier J, Verstockt B, Abreu C, et al.
J Crohns Colitis . 2021 Mar; 15(6):879-913. PMID: 33730753
No abstract available.
3.
Severyns T, Kirchgesner J, Lambert J, Thieblemont C, Amiot A, Abitbol V, et al.
J Crohns Colitis . 2020 Mar; 14(9):1222-1230. PMID: 32161943
Background And Aims: The prognosis of lymphoma that occurs in patients with inflammatory bowel disease [IBD] is poorly known. Methods: A multicentre retrospective cohort analysis was done in seven French...
4.
Fonteneau L, Le Meur N, Cohen-Akenine A, Pessel C, Brouard C, Delon F, et al.
Rev Epidemiol Sante Publique . 2017 Jun; 65 Suppl 4:S174-S182. PMID: 28624133
Background: The public health burden resulting from infectious diseases requires efforts in surveillance and evaluation of health care. The use of administrative health databases (AHD) and in particular the French...
5.
Kirchgesner J, Lemaitre M, Rudnichi A, Racine A, Zureik M, Carbonnel F, et al.
Aliment Pharmacol Ther . 2016 Oct; 45(1):37-49. PMID: 27781286
Background: Management of inflammatory bowel disease (IBD) has evolved in the last decade. Aim: To assess IBD therapeutic management, including treatment withdrawal and early treatment use in the current era...
6.